tetano
Editor, Senior Moderator
Infect Disord Drug Targets
. 2020 Nov 26.
doi: 10.2174/1871526520999201126203510. Online ahead of print.
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases
Fereshteh Ghiasvand[SUP] 1 [/SUP], Maryam Ghadimi[SUP] 2 [/SUP], Sara Sadr[SUP] 3 [/SUP], Fatemeh Jafari[SUP] 4 [/SUP], Navid Manafi[SUP] 4 [/SUP], Zahra Ah-Madinejad[SUP] 1 [/SUP], Samaneh Tirgar[SUP] 5 [/SUP], Seyed Ahmad Seyed Alinaghi[SUP] 6 [/SUP]
Affiliations
Abstract
Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is lim-ited data on its efficacy. We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.
Keywords: Atazanavir; Azithromycin; Coronavirus disease 2019 (COVID-19); Hydroxychloroquine; Ritonavir; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
. 2020 Nov 26.
doi: 10.2174/1871526520999201126203510. Online ahead of print.
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases
Fereshteh Ghiasvand[SUP] 1 [/SUP], Maryam Ghadimi[SUP] 2 [/SUP], Sara Sadr[SUP] 3 [/SUP], Fatemeh Jafari[SUP] 4 [/SUP], Navid Manafi[SUP] 4 [/SUP], Zahra Ah-Madinejad[SUP] 1 [/SUP], Samaneh Tirgar[SUP] 5 [/SUP], Seyed Ahmad Seyed Alinaghi[SUP] 6 [/SUP]
Affiliations
- PMID: 33243134
- DOI: 10.2174/1871526520999201126203510
Abstract
Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is lim-ited data on its efficacy. We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.
Keywords: Atazanavir; Azithromycin; Coronavirus disease 2019 (COVID-19); Hydroxychloroquine; Ritonavir; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).